Factors predictive of recurrence, metastasis and death in node‐negative penile squamous cell carcinoma: A retrospective multicentre cohort study

Author:

O'Connell Katie A.12ORCID,Thomas Jacob L.34,Murad Fadi1,Zhou Guohai5,Sonpavde Guru P.6,Mossanen Matthew7,Clinton Timothy N.7,Ji‐Xu Antonio8,Spiess Philippe E.9,Rossi Anthony M.34,Schmults Chrysalyne D.1

Affiliation:

1. Brigham & Women's/Dana‐Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA

2. Department of Dermatology Vanderbilt University Medical Center Nashville Tennessee USA

3. Division of Dermatology Memorial Sloan Kettering Cancer Center New York City New York USA

4. Weill Cornell Medical College New York City New York USA

5. Center for Clinical Investigation Brigham and Women's Hospital Boston Massachusetts USA

6. AdventHealth Cancer Institute Orlando Florida USA

7. Division of Urology Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA

8. Department of Dermatology University of California, Davis, School of Medicine Sacramento California USA

9. Moffitt Cancer Center Tampa Florida USA

Abstract

AbstractBackgroundPenile squamous cell carcinoma (PSCC) carries significant morbidity and mortality. Literature is limited regarding prognostic factors, especially prognostic factors for development of metastasis.ObjectivesTo identify independent prognostic factors associated with poor outcomes, defined as local recurrence (LR), metastasis and disease‐specific death (DSD) in clinically node‐negative PSCC undergoing local therapy.MethodsThirty‐two‐year Retrospective Multicenter Cohort Study of 265 patients with histologically diagnosed PSCC at three tertiary care centres. Predictive models based on patient or tumour characteristics were developed.ResultsLocal recurrence occurred in 56 patients, metastasis in 52 patients and DSD in 40 patients. In multivariable models, the following five factors were independent prognostic factors based on subhazard ratio (SHR): history of balanitis (LR SHR: 2.3; 95% CI 1.2–4.2), poor differentiation (metastasis SHR 1.9; 95% CI 1.0–3.6), invasion into the corpora (metastasis SHR: 3.0; 95% CI 1.5–5.8 and DSD SHR: 4.5; 95% CI 1.7–12.1), perineural invasion (PNI) (metastasis SHR: 2.8; 95% CI 1.4–5.5 and DSD SHR: 3.5; 95% CI, 1.6–7.8) and a history of phimosis (DSD SHR: 2.5; 95% CI 1.2–5.3). The 5‐year cumulative incidence of metastasis was higher for tumours with PNI [cumulative incidence function (CIF) = 55%, 95% CI 38–75 vs. CIF 15%, 95% CI 11–22], corporal invasion (CIF: 35%, 95% CI 26–47 vs. 12%, 95% CI 7–19) and poorly differentiated tumours (CIF = 46%, 95% CI 31–64 vs. CIF 15%, 95% CI 11–22).ConclusionsHistory of balanitis, history of phimosis, PNI, corporal invasion and poor differentiation are independent risk factors associated with poor outcomes. Since poor differentiation and PNI currently constitute only T1b disease, prognostic staging can likely be improved.

Funder

National Institutes of Health

Publisher

Wiley

Reference32 articles.

1. Quality of Life for Patients Treated for Penile Cancer

2. Penile cancer epidemiology and risk factors

3. Association between HPV infection and penile cancer and penile intraepithelial neoplasia: a retrospective observational study;Guimaraes MJ;J Eur Acad Dermatol Venereol,2023

4. National Comprehensive Cancer Network.Penile Cancer (Version 1.2023). [Internet]. [updated 2023; cited 2023 Apr 30]. Available from:https://www.nccn.org/professionals/physician_gls/pdf/penile.pdf

5. The Prognostic Index

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3